Antibody Treatment Makes Inroads Against Multiple Myeloma
MONDAY, Dec. 12, 2022 (HealthDay News) — An experimental immunotherapy appears highly effective in attacking bone marrow cancer, with nearly three in four patients responding to the treatment, new clinical trial results show. The drug, talquetamab, works by binding to the body’s immune cells as well as to multiple myelomaContinue Reading